Presentation Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation Presenter: T. Tada June 01, 2012
News Daily News CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events L.A. McKeown June 01, 2012
Presentation ACC 2012 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial Presenter: Myeong-Ki Hong March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
Presentation ACC 2012 Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial Presenter: Hyo-Soo Kim March 24, 2012
News Daily News Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All Yael L. Maxwell December 14, 2011
News Daily News DES Associated with Less Downstream Lesion Development than BMS L.A. McKeown November 04, 2011
News Industry News Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System November 02, 2011
News Daily News HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen Leah Lawrence September 29, 2011
News Conference News Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy September 02, 2011
News Daily News Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness Caitlin E. Cox June 24, 2011
News Daily News HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years Jason Kahn June 13, 2011
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011
News Daily News Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year Leah Lawrence April 26, 2011
News Industry News Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial April 04, 2011